- Steven J. Hatfill, a former White House COVID-19 advisor under Trump and advocate for hydroxychloroquine (HCQ) as an early COVID-19 treatment, has been appointed as a special adviser to the HHS’ Administration for Strategic Preparedness and Response (ASPR).
- Hatfill defended HCQ’s safety and efficacy, citing thousands of studies and Trump’s use of the drug, despite federal agencies revoking its emergency authorization in 2020 over safety concerns and disputed evidence.
- In his new role, Hatfill aims to improve readiness for future pandemics by analyzing global disease threats including influenza, bird flu and emerging pathogens.
- While some medical professionals (e.g., Dr. Joseph Varon) support his appointment as a step toward rebuilding trust, critics (e.g., Public Citizen’s Robert Steinbrook) argue HCQ’s ineffectiveness is settled science and warn against ideology influencing policy.
- Hatfill’s past includes involvement in Trump’s crusade to expose election fraud and a wrongful link to the 2001 anthrax attacks, raising questions about how his tenure may impact public health credibility.
(Natural News)—A scientist who endorsed hydroxychloroquine (HCQ) as a treatment for the Wuhan coronavirus (COVID-19) during the early days of the pandemic has been appointed to a key position at the Department of Health and Human Services (HHS).
Steven J. Hatfill, who previously served as a White House COVID-19 advisor during President Donald Trump’s first term, was recruited again for the real estate mogul’s second term – albeit in a new role this time. According to the Washington Post (WaPo), Hatfill began his second week as a special adviser in the director’s office of the Administration for Strategic Preparedness and Response (ASPR) on Monday, May 5.
The ASPR is an agency tasked with pandemic readiness and biodefense, two fields Hatfill is no stranger to. Nevertheless, his appointment underscores lingering divisions over COVID-19 treatments that go against conventional medical advice.
Hatfill, a former Army biodefense researcher, gained attention in 2020 for championing HCQ as an early intervention for COVID-19 despite pushback from federal health agencies and mainstream medical experts. He defended his stance in an interview with WaPo Saturday, May 3.
“They gave the drug to the president. It is a safe drug,” said Hatfill, referencing Trump’s use of HCQ when he contracted COVID-19. The virologist also cited “5,000 controlled, randomized [and] peer-reviewed studies” that attested to HCQ’s safety and efficacy when administered promptly.
Hatfill also reiterated his commitment to “get us ready for the next pandemic.” He expressed plans to work with other scientists at the ASPR to build “complete awareness of the scientific literature, not just for influenza, bird flu or COVID-19 – but other global diseases that could represent a threat to the United States.”
Medical experts attest to HCQ’s effectiveness
The Food and Drug Administration initially granted HCQ emergency use authorization in March 2020. But the agency revoked it three months later, citing cardiac risks and a lack of proven benefit. Critics, including Hatfill, argue that flawed studies – such as those administering the drug too late or at toxic doses – skewed the evidence.
Other medical experts also attested to HCQ’s effectiveness. Texas physician Dr. Mary Talley Bowden, who treated thousands of COVID-19 patients, said HCQ caused no serious side effects in her practice. Biological warfare expert Dr. Meryl Nass meanwhile noted the paradox of HCQ being deemed safe for lupus and malaria, but suddenly “dangerous” for COVID-19. (Related: Doctor who developed HCQ protocol has now successfully treated thousands of COVID-19 patients.)
Dr. Joseph Varon, president and chief medical officer of the Independent Medical Alliance (IMA), praised HHS for “recognizing the value of voices like Hatfill.” According to Varon, Hatfill’s appointment is a step toward “rebuilding public trust” in healthcare. Formerly known as the Front Line COVID-19 Critical Care Alliance, the IMA was among the proponents of HCQ t0 address SARS-CoV-2 infection.
But not everyone welcomed the virologist’s appointment, including Robert Steinbrook, health research group director for the progressive nonprofit Public Citizen. He argued that HCQ’s purported ineffectiveness against COVID-19 is settled science, noting that officials like Hatfill “should evaluate medicines based on evidence, not personal views.”
Hatfill’s name is also embroiled in controversies outside HCQ. Emails released by a Democrat-led House subcommittee revealed Hatfill’s involvement in Trump’s crusade to expose election fraud after the 2020 elections. His past also includes a wrongful link to the 2001 anthrax attacks, which cost him his job before a $4.6 million settlement with the Department of Justice.
As Hatfill assumes his new role, his tenure may test the balance between scientific rigor and ideological persistence in public health. With ASPR’s future uncertain – with the agency potentially being folded into the Centers for Disease Control and Prevention – his focus on global disease threats could either bridge divides or deepen them.
Visit Pandemic.news for more similar stories. Watch this February 2023 episode of “The Zelenko Report” on Brighteon.TV, where Dr. Steven Hatfill talks about HCQ with Ann Vandersteel.
This video is from the BrighteonTV channel on Brighteon.com.
More related stories:
- Dr. Robert Malone: FDA, BARDA blocked the use of HCQ as a Covid treatment.
- Nurse Erin Olszewski: HCQ and zinc better treatments for Covid – Brighteon.TV.
- Dr. Steven Hatfill tells Ann Vandersteel: There’s no valid medical reason for mass vaccination of kids and young adults – Brighteon.TV.
Sources include:
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.